Aurobindo Pharma Ltd.

BSE: 532540 NSE: Aurobindo Pharma ISIN:  INE467B01029 SECTOR: IT Software Company Company’s Website: IPO Date & Price: July 29, 2004 | Rs.

Aurobindo Pharma Overview:

Stock Symbol in NSEStock Symbol in BSECurrent PriceMarket Cap. (Cr)P/E RatioCurrent EPS
NSE:AUROPHARMABSE: 524804₹673.90₹39,486.40₹7.57₹89.00
52 Week High52 Week LowDay OpenDay HighDay LowVolumes
Current Price Fall From 52W high How Near from 52Week Low?Today ChangesAurobindo Pharma Ltd.Outstanding SharesFace valuelast Traded Time
36.66%7.92%12.10585,900,032.00₹1.0012/7/2021 15:30:00

Aurobindo Pharma

Its the Indian No-1 multinational information service and consulting Provider company. Aurobindo Pharma is the Subsidiary Company of TATA Group and it’s founded in 1968.

Aurobindo Pharma Sector Performance and Peer Comparison with Sector Analysis:

Did You Know?

<Space for Feature Image>

  • Aurobindo Pharma is the
  • Its Belong to Group.

Balance Sheets & Profit & Loss Account:

YearMar 2009Mar 2010Mar 2011Mar 2012Mar 2014Mar 2013Mar 2015Mar 2016Mar 2017Mar 2019Mar 2020Mar 2018
Net Profit100563563-1241,1732941,5762,0252,3022,3652,8312,423
EPS in Rs1.7910.021.9019.874.9226.5534.6138.8940.3648.3241.36
Dividend Payout %24%5%10%-24%7%15%8%7%6%6%6%6%
Grouth Rates463.00%0.00%-122.02%298.98%-337.10%34.36%28.49%13.68%-2.39%19.70%5.26%
Avearge Grouth Rates231.50%113.66%60.57%0.97%56.20%52.24%47.42%38.22%36.54%42.74%

Aurobindo Pharma Share Price Forecast Based on Current Growth +5/-5:

Share Price and EPS Forecast Based on Current Average Growth Rates:

Next 5 Year (CG)Next 10 Year (CG)Next 20 Year (CG)

Share Price and EPS Forecast Based on Current Average Growth Rates Plus 5%:

Next 5 Year (CG+5%)Next 10 Year (CG+10%)Next 20 Year (CG+20%)

Share Price and EPS Forecast Based on Current Average Growth Rates Minus 5%:

Next 5 Year (CG-5%)Next 10 Year (CG-10%)Next 20 Year (CG-20%)

Aurobindo Pharma Quarterly Result, Date & Street Estimate:

Fundamental Analysis of Aurobindo Pharma:

Aurobindo Pharma Share Long Term Investment Price Target:

V-Guard Long Term Investment TagetsPriceQnt.Ratio
Lot-1₹744.7320 [1X]
Lot-2₹691.5440 [2X]
Lot-3₹638.3480 [4X]
Lot-4₹585.15180 [8X]

Aurobindo Pharma Fundamentals SWAT Analysis by AMT

 Strengths, Weaknesses, Opportunities, and Threats of Aurobindo Pharma


  • Strengths Analysis will coming Soon.


  • Weakness Analysis will coming Soon.


  • Opportunity Analysis will coming Soon.


  • Threats Analysis will coming Soon.

Where we can See Aurobindo Pharma in Next 5 Year, 10 Year & 20 Year?

Technical Analysis of Aurobindo Pharma:

Aurobindo Pharma Share Weekly Swing Trading Price Target:

Demand And Supply ZoneSupport LevelsSupport PriceResistance LevelsResistance Price

Aurobindo Pharma Share Today Intraday Price Target:

V-Guard Share Price IntradayTarget Today [Short Selling]V-Guard Share Price IntradayTarget Today [Long Buying]

FAQ on Aurobindo Pharma:

Is it Good to Buy Aurobindo Pharma Share?

Yes, Aurobindo Pharma is India Number-1 IT Software company, with lots business potential in next few year. Its Fundamentally strong Stock we recommend to buy at around 20-25 PE Ration price target. Anyway This company is quite famous for Good Dividends.

Is Aurobindo Pharma Debt Free Company?

Aurobindo Pharma is a Debt free company. Its can easily survived any down turn for 5-10 Quarter business growth.

Is Aurobindo Pharma Overvalued?

Currently Aurobindo Pharma is Trading at P/E Ratio which is

Is Aurobindo Pharma Better than Infosys?

Both and working as a

Why Aurobindo Pharma Share Price is Falling?

Do to Covid-19 pandemic Aurobindo Pharma Share drastically fall.

Why Aurobindo Pharma Share Price is Going Up?

Is Aurobindo Pharma Good for Long Term Investment?

Its depend on when you and at what price you have buy this share, Aurobindo Pharma at 20-25 P/E Ration is a excellent buy call for long Term Investment.

Aurobindo Pharma’s Products/Projects:


IPO, Split, Bonus, Dividend Buyback History:

Aurobindo Pharma First IPO was initiate on July 29, 2004. equity shares were put on sale during the IPO with a price band of Rs -Rs per equity share.

[ninja_tables id=”*******************SBDB*****************************”

Company Profile:

CEO NameArvind Vasudeva
CFO NameSudhir Singhi
CEO Salary9.5 crore
Company AddressAurobindo Pharma Limited, Water Mark Building, Plot No. 11, Survey no.9, Kondapur, Hitech City, Hyderabad 500 084, Telangana, India.
Contact Number+91-40-66725000
Email Address[email protected]

Declaration: Investing in the Stock market is full of Risky. AllMoneyTips.COM doesn’t give any guarantee or warranted on its investment advice. Do your research before investing in the stock market. Our Forecast and buying selling levels of stocks is based on price action and demand and supply zone. There is no guarantee come with our prediction. Take it as advice only. We are not responsible for your losses on your investments.